We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 21, 2020

Therapeutic Efficacy of Bifidobacterium animalis subsp. lactis BB‐12 in Infant Colic

Alimentary Pharmacology & Therapeutics


Additional Info

Disclosure statements are available on the authors' profiles:

Alimentary Pharmacology & Therapeutics
The Therapeutic Efficacy of Bifidobacterium animalis subsp. lactis BB‐12® in Infant Colic: A Randomised, Double Blind, Placebo‐Controlled Trial
Aliment. Pharmacol. Ther. 2019 Dec 03;1(1)1, R Nocerino, F De Filippis, G Cecere, A Marino, M Micillo, C Di Scala, C de Caro, A Calignano, C Bruno, L Paparo, AM Iannicelli, L Cosenza, Y Maddalena, G Della Gatta, S Coppola, L Carucci, D Ercolini, R Berni Canani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading